News from janssen pharmaceutical companies of johnson

Jan 08, 2014, 18:17 ET

Janssen Pharmaceutical Companies of Johnson & Johnson Submit Citizen Petition to the U.S. FDA Regarding Naming of Biosimilars

Ask Agency to require that biosimilars bear distinguishable names to enhance patient safety The Janssen Pharmaceutical Companies of Johnson...

Nov 30, 2012, 09:47 ET

Janssen erklärt Absicht, Patente von Darunavir in ressourcenknappen Gegenden nicht durchzusetzen

- Die Strategie zielt auf die Unterstützung nachhaltiger Versorgung mit medizinisch vertretbarem, generischem Darunavir in Sub-Sahara-Afrika...

Nov 29, 2012, 16:28 ET

Janssen anuncia su intención de no imponer las patentes para darunavir en entornos con recursos limitados

- La política pretende apoyar el suministro sostenible de darunavir genérico médicamente aceptable en el África subsahariana...

Nov 29, 2012, 14:16 ET

Janssen annonce son intention de ne pas exécuter ses brevets sur le Darunavir dans les régions à ressources limitées

-- Une politique destinée à favoriser l'approvisionnement viable en Darunavir générique médicalement autorisé en...

Nov 29, 2012, 09:00 ET

Janssen Announces Intent Not to Enforce Patents for Darunavir in Resource-Limited Settings

 The Janssen Pharmaceutical Companies of Johnson & Johnson today announced their intention not to enforce the patents they own and control...

Dec 08, 2011, 16:21 ET

Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765

 Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ), announced today that it has executed...

Nov 10, 2011, 14:00 ET

Janssen Pharmaceutical Companies Launch Healthy Minds Initiative to Spur Neuroscience Collaboration and Support Millions Suffering from Brain Disorders

Janssen Pharmaceutical Companies of Johnson & Johnson ("Janssen") today announced the launch of Healthy Minds, a comprehensive initiative to...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer